Literature DB >> 22785230

Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses.

P Bergqvist1, A Stensson, L Hazanov, A Holmberg, J Mattsson, R Mehr, M Bemark, N Y Lycke.   

Abstract

Whereas gut IgA responses to the microbiota may be multi-centered and diverse, little is known about IgA responses to T-cell-dependent antigens following oral immunizations. Using a novel approach, gut IgA responses to oral hapten (4-hydroxy-3-nitrophenyl)acetyl-cholera toxin (NP-CT) conjugates were followed at the cellular and molecular level. Surprisingly, these responses were highly synchronized, strongly oligoclonal, and dominated by affinity matured cells. Extensive lineage trees revealed clonal relationships between NP-specific IgA cells in gut inductive and effector sites, suggesting expansion of the same B-cell clone in multiple Peyer's patches (PPs). Adoptive transfer experiments showed that this was achieved through re-utilization of already existing germinal centers (GCs) in multiple PPs by previously activated GC GL7(+) B cells, provided oral NP-CT was given before cell transfer. Taken together, these results explain why repeated oral immunizations are mandatory for an effective oral vaccine.

Mesh:

Substances:

Year:  2012        PMID: 22785230     DOI: 10.1038/mi.2012.56

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  42 in total

Review 1.  Clonal and cellular dynamics in germinal centers.

Authors:  Gabriel D Victora; Luka Mesin
Journal:  Curr Opin Immunol       Date:  2014-03-27       Impact factor: 7.486

Review 2.  Old questions, new tools: does next-generation sequencing hold the key to unraveling intestinal B-cell responses?

Authors:  O Pabst; H Hazanov; R Mehr
Journal:  Mucosal Immunol       Date:  2014-11-12       Impact factor: 7.313

3.  Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota.

Authors:  Cornelia Lindner; Irene Thomsen; Benjamin Wahl; Milas Ugur; Maya K Sethi; Michaela Friedrichsen; Anna Smoczek; Stephan Ott; Ulrich Baumann; Sebastian Suerbaum; Stefan Schreiber; André Bleich; Valérie Gaboriau-Routhiau; Nadine Cerf-Bensussan; Helena Hazanov; Ramit Mehr; Preben Boysen; Philip Rosenstiel; Oliver Pabst
Journal:  Nat Immunol       Date:  2015-06-29       Impact factor: 25.606

Review 4.  The regulation of gut mucosal IgA B-cell responses: recent developments.

Authors:  N Y Lycke; M Bemark
Journal:  Mucosal Immunol       Date:  2017-07-26       Impact factor: 7.313

Review 5.  What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Lessons from the Antibody Response to HIV-1.

Authors:  Gabriel D Victora; Hugo Mouquet
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

6.  BCR selection and affinity maturation in Peyer's patch germinal centres.

Authors:  Huan Chen; Yuxiang Zhang; Adam Yongxin Ye; Zhou Du; Mo Xu; Cheng-Sheng Lee; Joyce K Hwang; Nia Kyritsis; Zhaoqing Ba; Donna Neuberg; Dan R Littman; Frederick W Alt
Journal:  Nature       Date:  2020-05-06       Impact factor: 49.962

7.  B cell superantigens in the human intestinal microbiota.

Authors:  Jeffrey J Bunker; Christoph Drees; Andrea R Watson; Catherine H Plunkett; Cathryn R Nagler; Olaf Schneewind; A Murat Eren; Albert Bendelac
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

Review 8.  New concepts in the generation and functions of IgA.

Authors:  Oliver Pabst
Journal:  Nat Rev Immunol       Date:  2012-10-29       Impact factor: 53.106

Review 9.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

Review 10.  IgA Responses to Microbiota.

Authors:  Jeffrey J Bunker; Albert Bendelac
Journal:  Immunity       Date:  2018-08-21       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.